Innovative Vaccine Platform VaxForm has developed the QYNDR oral delivery platform, which is revolutionizing mucosal vaccination and offers a new approach to immunization that could appeal to healthcare organizations and vaccine distributors seeking innovative solutions.
COVID-19 Focus The company's active development of oral COVID-19 vaccines positions it as a potential partner for organizations involved in pandemic response, vaccine manufacturing, and global health initiatives seeking accessible and thermostable vaccination options.
Recent Scientific Releases VaxForm’s publication in the journal Vaccines highlights its research credibility and emerging expertise, making it attractive for academic collaborations, government agencies, and pharmaceutical firms interested in immune response technology.
Strategic Partnerships Collaborations with entities such as US Specialty Formulations and support from the Ben Franklin Partnership showcase VaxForm’s network and funding avenues, indicating opportunities for joint ventures and sponsored research projects.
Growth and Funding Potential With revenue estimates between one and ten million dollars and recent funding of 256K, VaxForm presents opportunities for sales of biotechnological research tools, platform licensing, and contract manufacturing services to larger firms scaling vaccine production.
VaxForm uses 8 technology products and services including Sucuri, WordPress, RequireJS, and more. Explore VaxForm's tech stack below.
| VaxForm Email Formats | Percentage |
| First.Last@vaxform.com | 88% |
| F.Last@vaxform.com | 12% |
Biotechnology ResearchPennsylvania, United States2-10 Employees
VaxForm specializes in the development of vaccine formulations. Our QYNDR oral delivery platform is revolutionizing mucosal vaccination. Press Releases: 24Sep2024 - VaxForm publishes manuscript in the journal Vaccines entitled "Formulation Attributes Impact Immune Profile of an Oral and Thermostable COVID-19 Subunit Vaccine" https://www.mdpi.com/2076-393X/12/10/1087/pdf
Company Overview
Funding & FinancialsVaxForm has raised a total of $256K of funding over 2 rounds. Their latest funding round was raised on Sep 02, 2020 in the amount of $256K.
VaxForm's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsVaxForm has raised a total of $256K of funding over 2 rounds. Their latest funding round was raised on Sep 02, 2020 in the amount of $256K.
VaxForm's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com